Two functional gene polymorphisms (−607C>A and −137 G>C) replace transcription factor binding sites and expression level of IL-18. 13 Plenty of studies have examined the association among IL-18 SNPs and inflammatory and/or autoimmune conditions such as systemic lupus erythematosus and rheumatoid arthritis. [14] [15] [16] Only one study examined the roles of IL-18 SNPs in AA disease, and they reported that the −137G>C and Ser35Ser polymorphisms were associated with AA.
IL-18, which stimulates IFN-γ, is a major cytokine in the Th1 response and affects the development of autoimmune, inflammatory, and infectious diseases. For those reasons, the study hypothesized that rs1946518 and rs187238 SNPs may be associated with etiopathogenesis of AA.
| MATERIALS AND METHODS

| Subjects
The study included 200 patients with AA (mean age ± SD:
36.62 ± 9.6 years) and 200 control subjects (mean age ± SD:
37.38 ± 11.31). In patients with AA, 123 were males and 77 were females, and among the control subjects, 120 were males and 80 were females. The patients with AA and control subjects were collected from Dermatology Clinic of Gaziosmanpasa University, Turkey. The criteria for the identification of AA were regarded standard criteria. 17 Clinical data were acquired from 200 patients with AA. The control subjects consist of patients with no AA history, who were referred to dermatology clinic for other reasons. Our study protocol was approved by the Gaziosmanpasa University hospital's ethics committee. Written informed consent was obtained from both patients with AA and control subjects, who were also acknowledged about the blood sampling for rs187238 and rs1946518 SNPs genotype analyses.
| DNA isolation
Peripheral blood samples from both patients with AA and control subjects were collected, and genomic DNAs (gDNA) were purified using a
GeneJET gDNA purification kit (Thermo Scientific™, USA).
| Genotyping
Single nucleotide polymorphism (SNP) genotyping was examined using sequence-specific primer-polymerase chain reaction (SSP-PCR) method, according to the previous reports. 18 For rs 1946518
and rs187238 polymorphisms, the PCR primers and PCR product lengths are shown in Table 1 Agarose gel electrophoresis is used to visualize the PCR products. Categorical variables were evaluated appropriately using the chisquare test. Odds ratios (ORs) with 95% confidence intervals (CIs)
| Statistical analysis
were used, and P values less than .05 were regarded statistically significant and were two-tailed.
| RESULTS
Genotype distribution and allelic frequencies of rs187238 and rs1946518 SNPs located in the promoter site of IL-18 gene, respectively, were examined in patients with AA and control group.
The demographical characteristics of patients with AA and control subjects in our study groups are summarized in Table 2 . According to gender distribution, there were no significant differences among patients and control subjects (P = .84). There was no significant mean age differences among patients with AA and control subjects (P = .483). Baseline clinical and demographical characteristics of patients with AA are demonstrated in Table 3 . No difference was
shown among clinical and demographical characteristics of patients with AA and rs187238 and rs1946518 polymorphisms. Genotype distribution for rs187238 and rs1946518 promoter polymorphisms fits the HWE. The genotypic distributions and allelic frequencies of rs187238 and rs1946518 polymorphisms in patients with AA and control group are shown in Table 4 . For rs187238 polymorphism, the distribution of the wild G/G genotype was found significantly higher in patients with AA (64.5%) than in control group (46.5%).
The distribution of the G/C genotype was higher in controls (39.5%) than in patients (25.5%), and distribution of the C/C genotype was found significantly lower in patients with AA (10%) than in controls (14%). Genotype distribution of rs 187238 SNP was significantly different among patients with AA and controls (P = .0014).
The frequency of the allele G was significantly higher in patients (77.25%) than in control subjects (66.25%), while an important increase in the frequency of the allele C was shown in control subjects (33.75%) when compared to patients (22.75%) (P = .001, OR = 1.73, 95% CI = 1.27-2.37). The distribution of GC+CC (for the dominant model: GC+CC vs GG) was significantly higher among controls than patients (53.5% vs 35.5%, respectively, P = .0003, OR = 2.08, 95% CI = 1.39-3.12).
T Data were examined by analysis of variance and chi-square test, and mean ± standard deviation values are viewed for age and age at disease onset.
T A B L E 3 Baseline clinical and demographical characteristics of the 200 patients with AA
For rs1946518 polymorphism, the distribution of the wild C/C genotype was found significantly higher in patients with AA (37.5%) than in control subjects (25%). The distribution of the C/A genotype was found as higher in controls (55%) than in patients with AA (54%), and distribution of the A/A genotype was found significantly lower in patients with AA (8.5%) than in controls (%20). Genotype distribution of rs1946518 SNP was significantly different among patients and controls (P = .0008). The frequency of the −607/allele C was significantly higher in patients with AA (64.5%) than in control subjects (52.5%) while an important increase in the frequency of the A allele was viewed in control subjects (47.5%) when compared to patients with AA (35.5%) (P = .001, OR = 1.64, 95%CI = 1.24-
2.18). While the distribution of CA+AA (for the dominant model:
CA+AA vs CC) was significantly higher among controls than patients (75% vs 62.5%, respectively, P = .007, OR = 1.79, 95% CI = 1.17-2.77), the frequency of CC+CA (for the recessive model: CC+CA vs AA) was significantly higher among patients than controls (91.5% vs 8.5%, respectively, P = .001, OR = 2.68, 95% CI = 1.47-5.02).
| DISCUSSION
In AA, the molecular mechanisms that give rise to hair shedding are not still clear. 4 On the other hand, genetic factors have significant investigated the development of heart disease in AA-affected C3H/HeJ mice which are exposed to ACTH. SNP were found to be statistically different among patient and control groups (P = .0014 and P = .001, respectively). Genotype distribution and allele frequency of rs1946518 polymorphism were also found to be significantly different among patient and control groups (P = .0008
and P = .001, respectively). The distributions of −607/CC and −137GG
genotypes showed a significant increase, while genotypes −607/AA and −137/CC showed a significant decrease in patients with AA as compared to the control subjects.
IL-18 polymorphism was found to be associated with systemic lupus erythematosus (SLE), which is an immune-mediated disease. 16 Fouad and others investigated IL-18 SNPs (rs1946518, rs187238)
in patients with SLE, and they found that the distribution of −607/ CC genotype was significantly higher, while genotype −607/CA was significantly lower in patients with SLE than control individuals. In addition to plasma, IL-18 level was found to be significantly elevated in patients with SLE with genotype CC at −607. 14 and it also showed that the −137G>C and Ser35Ser polymorphisms were associated with AA disease. Also, they found that the frequency of the allele G of −137G>C polymorphism in the AA group was found higher than the control group (P = .023). There was a difference in our study compared to the study of Kim and others. Our study firstly
showed that there was an association among AA disease and IL-18 rs1946518 (−607C>A) polymorphism. Lee et al also found that serum IL-18 cytokine levels in patients with extensive AA were significantly elevated than in controls. 27 Finally, our study demonstrated that IL-18 SNPs, the −137/G and −607/C allelic variants which relate to the increased production of IL-18, may be a significant genetic factor for AA. The status explains the increased level of serum IL-18 in patients with AA. IL-18 SNP should be examined in large cohort, which contains different ethnic groups.
Furthermore, IL-18, its receptors, and inhibitors will be more important to understand the pathogenesis of AA.
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